Literature DB >> 25411688

10 years of surveillance of human tularaemia in France.

A Mailles1, V Vaillant.   

Abstract

Tularaemia has been mandatorily notifiable in France since October 2002. The surveillance aims to detect early any infection possibly due to bioterrorism and to follow up disease trends. We report the results of national surveillance from 2002 to 2012. A case is defined as a patient with clinical presentation suggestive of tularaemia and biological confirmation of infection or an epidemiological link with a biologically confirmed case. Clinical, biological and epidemiological data are collected using a standardised notification form. From 2002 to 2012, 433 cases were notified, with a median age of 49 years (range 2 to 95 years) and a male–female sex ratio of 1.8. Most frequent clinical presentations were glandular tularaemia (n=200; 46%) and ulceroglandular tularaemia (n=113; 26%). Most frequent at-risk exposures were handling hares (n=179; 41%) and outdoor leisure exposure to dust aerosols (n=217; 50%). Tick bites were reported by 82 patients (19%). Ten clusters (39 cases) were detected over the 10-year period, as well as a national outbreak during winter 2007/2008. The tularaemia surveillance system is able to detect small clusters as well as major outbreaks. Surveillance data show exposure to dust aerosols during outdoor leisure activities to be a major source of contamination in France.

Entities:  

Mesh:

Year:  2014        PMID: 25411688     DOI: 10.2807/1560-7917.es2014.19.45.20956

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  12 in total

1.  Francisella tularensis aortitis.

Authors:  M Briere; A Kaladji; F Douane; J P Breux; P Touroult-Jupin; S Boisset; S Edouard; C Biron; D Boutoille
Journal:  Infection       Date:  2015-07-20       Impact factor: 3.553

Review 2.  Ecology of Francisella tularensis.

Authors:  Sam R Telford; Heidi K Goethert
Journal:  Annu Rev Entomol       Date:  2019-10-10       Impact factor: 19.686

3.  Usefulness of a single-assay chemiluminescence test (Tularaemia VIRCLIA IgG + IgM monotest) for the diagnosis of human tularemia. Comparison of five serological tests.

Authors:  África Cubero; Carlos Durántez; Ana Almaraz; Luis Fernández-Lago; María P Gutiérrez; María J Castro; Miguel A Bratos; María Simarro; Gabriel A March; Antonio Orduña
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-27       Impact factor: 3.267

4.  Evaluation of In-House and Commercial Serological Tests for Diagnosis of Human Tularemia.

Authors:  Hadjila Yanes; Aurélie Hennebique; Isabelle Pelloux; Sandrine Boisset; Dominique J Bicout; Yvan Caspar; Max Maurin
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

5.  Evolutionary Insights into IL17A in Lagomorphs.

Authors:  Fabiana Neves; Joana Abrantes; Tereza Almeida; Paulo P Costa; Pedro J Esteves
Journal:  Mediators Inflamm       Date:  2015-12-15       Impact factor: 4.711

6.  Pulmonary tularaemia: a differential diagnosis to lung cancer.

Authors:  Astrid Kravdal; Øystein Olav Stubhaug; Anne Grete Wågø; Magnus Steien Sætereng; Dag Amundsen; Ruta Piekuviene; Annette Kristiansen
Journal:  ERJ Open Res       Date:  2020-06-29

7.  Severe infections due to Francisella tularensis ssp. holarctica in solid organ transplant recipient: report of two cases and review of literature.

Authors:  Olivier Bahuaud; Cécile Le Brun; Thomas Chalopin; Marion Lacasse; Julien Le Marec; Clémence Pantaleon; Charlotte Nicolas; Louise Barbier; Louis Bernard; Adrien Lemaignen
Journal:  BMC Infect Dis       Date:  2019-03-08       Impact factor: 3.090

8.  Early Diagnosis of Tularemia by Flow Cytometry, Czech Republic, 2003-20151.

Authors:  Aleš Chrdle; Pavlína Tinavská; Olga Dvořáčková; Pavlína Filipová; Věra Hnetilová; Pavel Žampach; Květoslava Batistová; Václav Chmelík; Amanda E Semper; Nick J Beeching
Journal:  Emerg Infect Dis       Date:  2019-10       Impact factor: 6.883

9.  A rapid real-time quantitative PCR assay to determine the minimal inhibitory extracellular concentration of antibiotics against an intracellular Francisella tularensis Live Vaccine Strain.

Authors:  Ronit Aloni-Grinstein; Ohad Shifman; Shlomi Lazar; Ida Steinberger-Levy; Sharon Maoz; Raphael Ber
Journal:  Front Microbiol       Date:  2015-11-03       Impact factor: 5.640

10.  Optimized MALDI TOF Mass Spectrometry Identification of Francisella tularensis Subsp. holarctica.

Authors:  Sofiane Regoui; Aurélie Hennebique; Thomas Girard; Sandrine Boisset; Yvan Caspar; Max Maurin
Journal:  Microorganisms       Date:  2020-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.